MAIA Biotechnology Inc’s recent filing unveils that its Director Smith Stan acquired Company’s shares for reported $16441.0 on Dec 05 ’25. In the deal valued at $1.20 per share,13,740 shares were bought. As a result of this transaction, Smith Stan now holds 4,580 shares worth roughly $6228.8.
Then, Vitoc Vlad bought 50,000 shares, generating $56,830 in total proceeds. Upon buying the shares at $1.14, the Chief Executive Officer now owns 881,421 shares.
Before that, Vitoc Vlad bought 22,000 shares. MAIA Biotechnology Inc shares valued at $23,019 were divested by the Chief Executive Officer at a price of $1.05 per share. As a result of the transaction, Vitoc Vlad now holds 853,421 shares, worth roughly $1.16 million.
Price Performance Review of MAIA
On Friday, MAIA Biotechnology Inc [AMEX:MAIA] saw its stock fall -17.07% to $1.36. Over the last five days, the stock has gained 13.33%. MAIA Biotechnology Inc shares have fallen nearly -37.04% since the year began. Nevertheless, the stocks have fallen -31.31% over the past one year. While a 52-week high of $2.74 was reached on 05/02/25, a 52-week low of $0.87 was recorded on 11/20/25.
Levels Of Support And Resistance For MAIA Stock
The 24-hour chart illustrates a support level at 1.2167, which if violated will result in even more drops to 1.0733. On the upside, there is a resistance level at 1.6267. A further resistance level may holdings at 1.8933.
How much short interest is there in MAIA Biotechnology Inc?
A steep rise in short interest was recorded in MAIA Biotechnology Inc stocks on 2025-11-28, dropping by -0.31 million shares to a total of 0.69 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-31 was 1.0 million shares. There was a decline of -45.46%, which implies that there is a negative sentiment for the stock.
